Biomarin Pharmaceutical Inc (BMRN)
Industry Biotechnology
This stock can be held in an Investment ISA and an Investment Account
Sell
$58.00
Buy
$60.00
$1.00 (+1.72%)
Prices updated at 17 May 2025, 00:08 EDT
| Prices minimum 15 mins delay
Prices in USD
Biomarin Pharmaceutical Inc is on rare-disease therapies. It develops and commercializes pharmaceuticals for serious diseases and medical conditions.
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
$59.73 - $57.82 | |
$94.85 - $52.93 | |
- | |
11,366.54m | |
21.95 | |
- | |
3,493,064 | |
1.96 | |
1,863,041.70 | |
0.40 | |
190.76m | |
US09061G1013 | |
2.70 | |
- |
Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.